张燕玲,杨晔,杨珍,等.内皮素受体 A 拮抗剂药效团模型的建立[J].世界科学技术--中医药现代化,2013,15(3): 471.
[3]
Piotrowski D W. Mineralocorticoid receptor antagonists for the treatment of hypertension and diabetic nephropathy [J]. J Med Chem, 2012, 55(18): 7957.
[4]
Pedram B, Oeveren A, Mais D E, et al. A tissue-selective nonsteroidal progesterone receptor modulator: 7, 9-difluoro-5-(3-methylcyclohex-2-enyl)-2, 2, 4-trimethyl-1, 2-dihydrochromeno quinoline[J]. J Med Chem, 2008, 51(13): 3696.
Ulmann A, Menard J, Corvol P. Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptors[J]. Endocrinology, 1975,97(1):46.
Hobler A, Kagawa N, Hutter M C, et al. Human aldosterone synthase: recombinant expression in E.coli and purification enables a detailed biochemical analysis of the protein on the molecular level[J]. J Ster Biochem Mol Biol, 2012,132(1): 57.